Essex Woodlands Portfolio Concentration: An All-Healthcare Holding Analysis
As of June 30, 2026, Essex Woodlands Management Inc.'s portfolio is entirely concentrated within the Healthcare sector.
On June 30, 2026, Essex Woodlands Management, Inc. maintained a fully concentrated investment strategy across its portfolio.
The firm's holdings are exclusively focused on companies operating in the dynamic Healthcare sector. This single-sector allocation represents 100% of their total portfolio value, amounting to $254.23 million.
Examining the largest positions reveals that Essex Woodlands holds five significant stocks:
- BIOVENTUS INC (BVS), valued at approximately $122.92 million, accounts for about 48.35% of the portfolio.
- MIMEDX GROUP INC (MDXG), valued at $108.55 million, makes up roughly 42.7% of the assets.
- EYEPOINT PHARMACEUTICALS INC (EYPT), valued at $15.51 million, contributes about 6.1% to the total value.
- TELA BIO INC (TELA), valued at $5.79 million, represents approximately 2.28% of the portfolio.
- MEDICINOVA INC (MNOV), valued at $1.46 million, holds a smaller allocation of around 0.57%.
This portfolio structure indicates a high degree of concentration within the Healthcare sector as of June 30, 2026. Essex Woodlands Management Inc.'s holdings are stable from the previous period, with no changes in share counts reported for these positions.
The complete allocation to Healthcare means that any assessment of this portfolio's risk profile must consider its vulnerability to sector-specific developments and events. Investors analyzing Essex Woodlands Management, Inc. should be aware of the significant exposure represented by these five holdings combined with their 100% sector allocation.